・これは、2018年4月16日にジャーナリスト向けに発行したサイエンス・アラートです。

・記事の引用は自由ですが、末尾の注意書きもご覧下さい。

＜海外SMC発サイエンス・アラート＞

妊娠中の鎮痛剤服用、胎児の生殖細胞数へ影響か ：海外専門家コメント

エディンバラ大の研究グループは妊娠中にイブプロフェンとアセトアミノフェンを服用した場合に胎児に与える影響を調べ、胎児の生殖細胞が減少する可能性があるとの論文を発表しました。今回の研究では試験管内での実験に加え、胎児由来の精巣と卵巣の組織をラットの体内に移植した上で鎮痛剤の影響を調べています。実際の胎児で同様の影響が見られるかはまだわからないとしています。論文は16日、Environmental Health Perspectivesに掲載されました。本件に関する専門家のコメントをお送りします。

論文リンク（抜粋）

Environmental Health Perspectives

Effects of exposure to acetaminophen and ibuprofen on fetal germ cell development in both sexes in rodent and human using multiple experimental systems

エディンバラ大プレスリリース：

https://www.ed.ac.uk/news/2018/painkillers-in-pregnancy-may-affect-baby-s-fertili

Dr Patrick O’Brien

Consultant Obstetrician and spokesperson for the Royal College of Obstetricians and Gynaecologists (RCOG)

原文

“This is an interesting study which suggests taking paracetamol and ibuprofen during pregnancy might affect the fertility of the unborn child by reducing the number of cells that give rise to sperm and eggs.

 

“It is important to note that this study was carried out on human fetal testes and ovaries and animal models, so definitive conclusions cannot be drawn.  It is also not possible to translate the findings into a recommendation on what would be a safe or unsafe amount of paracetamol or ibuprofen to take while pregnant.

 

“More research is needed into the long term effects of paracetamol and ibuprofen use in pregnancy on the fertility of the unborn child.

 

“Women should not be alarmed by the results of this study.  Paracetamol is widely accepted as a safe painkiller for pregnant women to take, and can be very beneficial when a pregnant woman is suffering with a migraine, for example.  We recommend that women follow current guidance and take the lowest effective dose of paracetamol for the shortest possible time.  If this doesn’t treat the pain, they should to speak to their GP, midwife, or obstetrician.  Pregnant women are generally advised to avoid taking ibuprofen as it is associated with an increased risk of compilations.”

Prof Ieuan Hughes

member of the Society for Endocrinology, and Emeritus Professor of Paediatric Endocrinology, University of Cambridge

原文

“This paper is a magnum opus of methodology from a well recognised research group exploring the effect and mechanism of analgesic exposure during pregnancy on the fetal gonads of offspring.  Clearly, this cannot be studied directly in humans but the Edinburgh group has utilised a number techniques with in vitro, ex vivo (using human fetal testis implants in rodents) and direct animal studies to assess the effects of acetaminophen (paracetamol) and ibuprofen.

 

“The doses used reflected those commonly used by adults.  The results showed that such exposure reduced the number of germ producing cells in both the fetal testis and ovary.  The observation affecting the developing ovary is particularly important as the finite number of eggs a female has for reproduction is set well before birth.  The mechanism appears to be via the action of prostaglandins which, the study shows, can be blocked by prostaglandin-inhibitors.  Another remarkable observation in this study was that these effects may be passed on to the next generation via epigenetic effects.

 

“So what does the latest study in this field mean for women who are pregnant and need to take an analgesic for some reason?  As with previous studies in this area, the authors emphasise that paracetamol is probably still safe in pregnancy but to use the smallest dose for the shortest time, as a precautionary principle.  However, there has now been a steady drip-feed of epidemiological and experimental studies reporting that analgesics taken during pregnancy may have adverse effects on the reproductive system of the offspring.  Is it not time for investigators in this field of endocrine disruption to get together to formulate a large scale prospective study of the potential health risks of women taking analgesics while pregnant?”

Dr Channa Jayasena

Society for Endocrinology and Senior Clinical Lecturer in Reproductive Endocrinology at Imperial College London

原文 

“Paracetamol and ibuprofen are commonly used during pregnancy.  However, over the last year, a growing number of reports have suggested that we might need to take a closer look at their safety in unborn babies.  This latest study raises the possibility that paracetamol and ibuprofen may reduce the growth of the ‘germ cells’ which later become eggs or sperm in unborn babies.  It is important to recognise that the study only looks at tissue in the lab, which limits its relevance in humans.  However, when its results are considered in the context of similar recent studies, they become more interesting.  While it is still premature to stop taking these important drugs, there is a growing case to investigate their safety for pregnant women.”

Dr Sarah Branch

Deputy Director of the MHRA’s Vigilance and Risk Management of Medicines Division

原文

“Women should avoid taking medicines during pregnancy unless absolutely necessary and should speak to their doctor, midwife or pharmacist before doing so.  Paracetamol is generally considered to be a safe treatment for pain relief during pregnancy but should be taken at the lowest possible dose for the shortest time.  Ibuprofen is not recommended for use during pregnancy.

 

“The safety of all medicines is carefully monitored.  These findings will be carefully evaluated, as with any study, to determine whether they have any implications for the safe use of paracetamol or ibuprofen.”

記事のご利用にあたって

マスメディア、ウェブを問わず、科学の問題を社会で議論するために継続して
メディアを利用して活動されているジャーナリストの方、本情報をぜひご利用下さい。
「サイエンス・アラート」「ホット・トピック」のコンセプトに関してはコチラをご覧下さい。

記事の更新や各種SMCからのお知らせをメール配信しています。

サイエンス・メディア・センターでは、このような情報をメールで直接お送りいたします。ご希望の方は、下記リンクからご登録ください。（登録は手動のため、反映に時間がかかります。また、上記下線条件に鑑み、広義の「ジャーナリスト」と考えられない方は、登録をお断りすることもありますが御了承下さい。ただし、今回の緊急時に際しては、このようにサイトでも全ての情報を公開していきます）【メディア関係者データベースへの登録】 http://smc-japan.org/?page_id=588

記事について

○ 私的／商業利用を問わず、記事の引用（二次利用）は自由です。ただし「ジャーナリストが社会に論を問うための情報ソース」であることを尊重してください（アフィリエイト目的の、記事丸ごとの転載などはお控え下さい）。

○ 二次利用の際にクレジットを入れて頂ける場合（任意）は、下記のいずれかの形式でお願いします：
・一般社団法人サイエンス・メディア・センター　・（社）サイエンス・メディア・センター
・（社）SMC　　・SMC-Japan.org

○ この情報は適宜訂正・更新を行います。ウェブで情報を掲載・利用する場合は、読者が最新情報を確認できるようにリンクをお願いします。

お問い合わせ先

○この記事についての問い合わせは「御意見・お問い合わせ」のフォーム、あるいは下記連絡先からお寄せ下さい：
一般社団法人 サイエンス・メディア・センター（日本）　Tel/Fax: 03-3202-2514